2023-08-22 18:12:58
Accessibility to quality medical services and pharmaceuticals is one of the central issues of health care. That is why one of the main challenges faced by public authorities and medical institutions is to find strategies to benefit the greatest number of people from therapeutic treatments without affecting the stability of health systems.
Last year the “Mexico Therapeutic Innovation and Pharma Forum” was held, a virtual event organized by the Bamberg Foundation and in which the urgency of promoting the efficiency of the public sector among its medical, financial and administrative departments was discussed, since only The coordination of these three sectors can guarantee a broader accessibility to innovative medicines and therapies in Mexico.
The drug acquisition process for therapeutic treatments works sequentially
Dr. Giota Panopoulou, specialist in health systems financing, expressed that “the process of including the purchase of medicines must be a continuous and collegiate work. The more people sit at a table, the less likely it is for dysfunction, corruption, and the more guarantee of a transparent and clear process.”
The process, in general, works sequentially. The medical area is the one that has a first step in the process of purchasing drugs for therapeutic treatments. Once the evaluation and purchase decision have been made, the administrative area of the clinical institution is involved to make the purchase. Meanwhile, the financial area approves a budget for the purchase.
There must be a balance between innovative and existing therapies
If you want to increase the accessibility of medicines, Jesús Efraín Flores, TecSalud’s chief of pharmacy, has indicated that “pharmaceutical services must focus on the patient’s experience…they have to be incorporated into practice, incorporated into the perspective and be closer to he”.
Likewise, this expert has indicated that the public sector has limited access to pharmaceutical treatments, so having a professional in Pharmacy could save expenses in therapeutic treatments by avoiding delivering wrong doses. One of these professionals could avoid lawsuits for errors in the dispensing of medicines, since they are in charge of reviewing the safety and suitability of the medicines when they are delivered.
Finally, it should be noted that there must be a balance between innovative and existing therapies. According to Dr. Gabriela Borrayo “today there are double and triple therapies to address some chronic diseases and also for secondary prevention… This will allow us to have better adherence, better control goals and, probably, fewer cardiovascular events in the future” .
#innovations #experienced #therapeutic #treatments #Mexico